Pleurocidin [K7,8,14,18R]

General Information


DRACP ID  DRACP04576

Peptide Name   Pleurocidin [K7,8,14,18R]

Sequence  GWGSFFRRAAHVGRHVGRAALTHYL

Sequence Length  25

UniProt ID  P81941 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial



Structure Information


PDB ID  6RSF 

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C129H192N44O29

Absent amino acids  CDEIKMNPQ

Common amino acids  AGR

Mass  325149

Pl  12.5

Basic residues  7

Acidic residues  0

Hydrophobic residues  11

Net charge  7

Boman Index  -4256

Hydrophobicity  -16.4

Aliphatic Index  70.4

Half Life 
  Mammalian: 5.5 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  6990

Absorbance 280nm  291.25

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 33247193

Title  A pleurocidin analogue with greater conformational flexibility, enhanced antimicrobial potency and in vivo therapeutic efficacy

Doi Not available

Year  2020

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  20612

DRACP is developed by Dr.Zheng's team.